Stephen Tobey resumes & CV records
Resumes
Stephen Tobey
Stephen W Tobey, Age 891498 S Shore Dr, Washington Island, WI 54246
Stephen Tobey Phones & Addresses
1498 S Shore Dr, Washington Island, WI 54246 (920) 847-2162
4201 Congress Dr, Midland, MI 48642 (517) 832-8946
123 Queen Palm Dr, Naples, FL 34114 (239) 530-0675
13 Queen Palm Dr, Naples, FL 34114 (941) 530-0675
Ann Arbor, MI
13 Queen Palm Dr, Naples, FL 34114
Mentions for Stephen W Tobey
Publications & IP owners
Us Patents
Hydroxypropyl Methocellulose Ether Compositions For Reduction Of Serum Lipid Levels
US Patent:
5766638, Jun 16, 1998
Filed:
Dec 8, 1995
Appl. No.:
8/569332
Inventors:
Stephen W. Tobey - Midland MI
Assignee:
The Dow Chemical Company - Midland MI
International Classification:
A61K 950
A61K 31715
A61K 31715
US Classification:
424499
Abstract:
The present invention concerns cool-water dispersible powder formulations of high molecular weight hydroxypropyl methylcellulose which has been milled to a specified particle size, with or without encrustation or other surface treatment, for dispersion into consumable liquids or for formulation of dry-mix powders, sauces, instant set puddings and baked goods for human consumption. The formulation is used for reduction of serum cholesterol levels. A process for preparing the formulation and its mode of administration is also provided.
Animal Litter
US Patent:
5014650, May 14, 1991
Filed:
Dec 28, 1989
Appl. No.:
7/458197
Inventors:
Cynthia W. Sowle - Mt. Pleasant MI
Stephen W. Tobey - Midland MI
Stephen W. Tobey - Midland MI
Assignee:
DowBrands Inc. - Indianapolis IN
International Classification:
A01K 1015
US Classification:
119171
Abstract:
Disclosed is an animal litter comprising a porous, inert solid substrate and a dry, particulate cellulosic ether. When animal urine contacts the animal litter there are produced gelled agglomerates containing the animal urine, polymer, and solid substrate. The gelled agglomerates have sufficient mechanical integrity to be conveyed as discrete entities thereby permitting animal urine to be physically removed from the litter box.
Effect Of Particle-Size Distribution Of Cellulose Ethers On Palatability Of Compositions
US Patent:
5281584, Jan 25, 1994
Filed:
Feb 28, 1992
Appl. No.:
7/843748
Inventors:
Stephen W. Tobey - Midland MI
Assignee:
The Dow Chemical Company - Midland MI
International Classification:
A21D 1002
A21D 208
A23L 10534
A61K 31715
A21D 208
A23L 10534
A61K 31715
US Classification:
514 57
Abstract:
The present invention is directed to a baked food composition comprising food ingredients and a water-soluble cellulose ether which is useful for reducing the low-density lipoprotein serum cholesterol level of an animal. Use of a specific particle-size distribution of the water-soluble cellulose ether results in compositions which are more palatable than known compositions.
Pharmaceutical Compositions And Uses Of Water-Soluble, High-Viscosity Grade Cellulose Ethers
US Patent:
5576306, Nov 19, 1996
Filed:
Dec 9, 1994
Appl. No.:
8/353949
Inventors:
Jennifer B. Dressman - Paris, FR
Christos Reppas - Athens, GR
Stephen W. Tobey - Midland MI
Cynthia W. Sowle - Carmel IN
Christos Reppas - Athens, GR
Stephen W. Tobey - Midland MI
Cynthia W. Sowle - Carmel IN
Assignee:
Dow Chemical Company - Midland MI
Board of Regents Acting for and on Behalf of the University of Michigan - Ann Arbor MI
Board of Regents Acting for and on Behalf of the University of Michigan - Ann Arbor MI
International Classification:
A01N 4304
A01N 2500
A61K 4700
A01N 2500
A61K 4700
US Classification:
514 57
Abstract:
Water-soluble, high-viscosity grade cellulose ether compositions are useful for the reduction of serum lipid levels, particularly total serum cholesterol, serum triglycerides, and low-density lipoprotein (LDL) levels and/or attenuate the postprandial rise of blood glucose levels in animals. The pharmaceutical uses of compositions for reducing cholesterol levels additionally include the treatment of diabetes and/or hypercholesterolemia, with avoidance of many of the undesirable side effects associated with other forms of treatment. The composition may be in the form of a prehydrated ingestible composition, such as a gelatin, or a comestible, such as a cookie. In addition, the compositions of the present invention are palatable to the patient, thereby enhancing patient compliance with the regimen.
Pharmaceutical Compositions And Uses Of Water-Soluble, High-Viscosity Grade Cellulose Ethers
US Patent:
5789393, Aug 4, 1998
Filed:
Jun 7, 1995
Appl. No.:
8/477371
Inventors:
Jennifer B. Dressman - Paris, FR
Christos Reppas - Athens, GR
Stephen W. Tobey - Midland MI
Cynthia W. Sowle - Carmel IN
Christos Reppas - Athens, GR
Stephen W. Tobey - Midland MI
Cynthia W. Sowle - Carmel IN
Assignee:
The Board of Regents of the University of Michgan - Ann Arbor MI
The Dow Chemical Company - Midland MI
The Dow Chemical Company - Midland MI
International Classification:
A61K 31715
C08B 1102
C08B 1100
C07H 1504
C08B 1102
C08B 1100
C07H 1504
US Classification:
514 57
Abstract:
Water-soluble, high-viscosity grade cellulose ether compositions are useful for the reduction of serum lipid levels, particularly total serum cholesterol, serum triglycerides, and low-density lipoprotein (LDL) levels and/or attenuate the postprandial rise of blood glucose levels in animals. The pharmaceutical uses of compositions for reducing cholesterol levels additionally include the treatment of diabetes and/or hypercholesterolemia, with avoidance of many of the undesirable side effects associated with other forms of treatment. The composition may be in the form of a prehydrated ingestible composition, such as a gelatin, or a comestible, such as a cookie. In addition, the compositions of the present invention are palatable to the patient, thereby enhancing patient compliance with the regimen.
NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.